About 200 reports

  • The U.S. Diagnosed Adult Migraine Population with Triptan Treatment Forecast (2018-2023)
  • The U.S. Migraine Treated Population by Drug Type (2018)

Among triptan treated patients, ##. ##% was treated with triptans only, ##. ##% was treated with triptan and prophylaxis and ##. ##% was treated with triptan and other acute classes.

  • OTC
  • United States
  • World
  • Forecast
  • Amgen Inc.
  • 7.1.7.7 TRIPTAN SWOT ANALYSIS
  • TRIPTANS HAVE BEEN SHOWN TO BE INEFFECTIVE IN A SUBSECTION OF MIGRAINEURS.

I know that in the USA there is one combination, one pill, but here we need to give one of triptan, one of NSAID.

  • OTC
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • TRIPTANS
  • MIGRAINE THERAPEUTICS MARKET

THE ACTIONS OF ERGOT ALKALOIDS AT ##-HT##B/ ##D RECEPTORS LIKELY MEDIATE THEIR ACUTE ANTIMIGRAINE EFFECTS.

  • OTC
  • United States
  • Market Segment
  • Market Size
  • Allergan plc
  • GLOBAL MIGRAINE DRUGS MARKET - MARKET SIZE AND FORECAST 2017-2022
  • Identifying factors impacting market growth

Sumatriptan is one of the most commonly used triptants as it is less expensive and is as effective as or better than most of the other triptans.

  • OTC
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co Ltd
  • Eli Lilly & Co.
  • hour wear time (upper arm) in healthy volunteers. The trial was registered with the U.S National Institutes of Health.
  • GALCANEZUMAB - DRUG PROFILE

Treatment includes anti-inflammatory (steroid) medicines and triptans.

  • OTC
  • Pain Relief
  • United States
  • Product Initiative
  • Zosano Pharma Corporation

EXECUTIVE SUMMARY ##.

  • OTC
  • Pain Relief
  • APAC
  • Market Shares
  • GALCANEZUMAB - DRUG PROFILE
  • registered with the U.S. National Institutes of Health.

In Part ## of the study, the ## participants will be randomized and receive ##. ## mg ZP-Triptan patch, two ##. ## mg ZP-Triptan patches, a ##. ## mg ZP-Triptan patch, a ##. ## mg oral zolmitriptan tablet, and a subcutaneous injection of sumatriptan.

  • OTC
  • Pain Relief
  • United States
  • Product Initiative
  • Zosano Pharma Corporation
  • DFN-15 - DRUG PROFILE

CTC is a first in class analgesic co-crystal with a molecular ratio of ##:## of tramadol hydrochloride and celecoxib.

  • OTC
  • Pain Relief
  • United States
  • Product Initiative
  • Pacira Pharmaceuticals, Inc.
  • NXN-188 is a first-in-class small molecule that is being developed for the treatment of migraine with aura and which incorporates both first-in-class nNOS inhibition and 5-HT agonism (the mechanism of action of triptans, the current
  • SEP 05, 2008: NEURAXON'S NXN-188 DEMONSTRATES PAIN RELIEF IN MIGRAINE WITH AURA

" Preclinical studies comparing NXN-## to triptans, the current standard of care in migraine therapy, demonstrated that NXN-## has multiple potential advantages over triptan therapy.

  • OTC
  • Pain Relief
  • United States
  • Product Initiative
  • NeurAxon, Inc.
  • 2.5.1 Migraine
  • Pain Therapeutics Market, Global, Epidemiology Patterns for Migraine, 2016-

The mechanism of action of triptans has long been in dispute.

  • OTC
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • Depomed, Inc.
  • May 09, 2017: Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes
  • 06/12/2017: Zosano Presents Additional Data from ZOTRIP Study at American Headache Society, Demonstrating Positive Results for Pain Freedom and Sustained Pain Freedom

" Zolmitriptan is one of the most potent triptans with regard to binding affinity at both ##HT-##d and ##HT-##b, and gains a secondary effect on both of these receptors through its active metabolite##.

  • OTC
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation

Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 ##.

  • OTC
  • APAC
  • World
  • Forecast
  • Market Size
  • JUN 20, 2018: ALDER BIOPHARMACEUTICALS TO PRESENT NEW DATA FURTHER HIGHLIGHTING EPTINEZUMAB'S EFFICACY PROFILE FOR MIGRAINE PREVENTION AT AMERICAN HEADACHE SOCIETY MEETING
  • EPTINEZUMAB - DRUG PROFILE

Company demonstrated that they conducted a study entitled with " eptinezumab reduced migraine frequency and triptan/ ergotamine use over weeks ##-##, and improved hit-## scores at months one and three.

  • OTC
  • United States
  • World
  • Product Initiative
  • Teva Pharmaceutical Industries Ltd.
  • Retail Value Sales of OTC Triptans by Market 2011-2021
  • Global Retail Value Sales of Top Five OTC Triptan Brands 2011/2016

OTC triptans: Triptans are analgesics used to treat migraine and cluster headaches.

  • Analgesic
  • OTC
  • Therapy
  • World
  • Demand
  • Adult Ketoprofen, Adult Naproxen and OTC Triptans Likely To Come Under Further Regulation in the Future

OTC triptans did well over 2019, albeit from a small base, as consumers use them for migraines and severe cluster headaches and do not have to have repeat prescription for these products.

  • OTC
  • Saudi Arabia
  • Demand
  • Adult Analgesics Experiences Declining Demand Although Niche of OTC Triptans Is Strongest Performer

However, one of the few exceptions to the negative trend was the positive strong performance recorded by adult OTC triptans following its change to OTC status mid-review period, recording ongoing high retail volume and current value growth in 2019.

  • OTC
  • Finland
  • Demand

Major Plays Intimidate Newer Arrivals Analgesics was driven by established options and consumers seldom chose generic varieties CATEGORY DATA Table ## Sales of Analgesics by Category: Value 2014-2019 Systemic Analgesics - Adult Analgesics -- Adult Acetaminophen -- Adult Aspirin -- Adult Comb

  • OTC
  • Slovenia
  • Demand
  • Namenda (memantine)
  • Sales of Top Anti-Migraine Products in 2017

Triptans have been dominating the anti-migraine market, however of late managed care is promoted to limit the use of triptans, due to their side-effect profile.

  • Hospital
  • OTC
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

OTC products with disease risk reduction claims are only allowed to have one month' s supply contained within bottles or blister strips with an outer carton box.

  • OTC
  • Malaysia
  • Demand

According to the institution, one fifth of value sales of these medicines come from the illegal market.

  • OTC
  • Bolivia
  • Demand

Triptans ##. ##. ##. ##. ##.

  • OTC
  • Pain Relief
  • APAC

Forever Living is one of the most successful players with its herbal vitamins and dietary supplements.

  • Gastrointestinal Drug
  • OTC
  • Tanzania
  • Demand
  • GlaxoSmithKline plc

While only ##% of the population aged ##-years-old or over were obese in 2019, this represented an increase of almost one percentage point from 2014.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • Uganda
  • Demand
  • RSP USD million
  • REPORT DEFINITIONS (3)

OTC triptans: Triptans are analgesics used to treat migraine and cluster headaches.

  • OTC
  • Demand
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • LIST OF CONTENTS AND TABLES
  • APPENDIX

However, one of the few exceptions to the negative trend was the positive strong performance recorded by adult OTC triptans following its change to OTC status mid-review period, recording ongoing high retail volume and current value growth in 2019.

  • Ophthalmic Solution
  • OTC
  • Vitamin
  • Finland
  • Demand

Honduras is one of the poorest countries in Central America, with one third of the population living on USD##. ## a day or less.

  • Gastrointestinal Drug
  • OTC
  • Vitamin
  • Honduras
  • Demand
  • HEADLINES

OTC triptans did well over 2019, albeit from a small base, as consumers use them for migraines and severe cluster headaches and do not have to have repeat prescription for these products.

  • OTC
  • Saudi Arabia
  • Demand
  • Cigalah Group
  • GlaxoSmithKline plc

One potential threat to international brands, though, is the availability of low-quality counterfeit products distributed under leading global brand names.

  • OTC
  • Pakistan
  • Demand
  • GlaxoSmithKline plc

Angelini Group Ranks Second With Its One Strong Brand Second-ranked Angelini Group only has one brand in the category, Tantum Verde, which continued to lead in terms of value sales in 2019.

  • OTC
  • Georgia
  • Demand

Direct sellers promote their products through network marketing seminars, one-on-one marketing schemes and the sharing of testimonials.

  • OTC
  • Cameroon
  • Demand
  • GlaxoSmithKline plc
  • Sanofi S.A.